Patent holdings for IPC class C40B 30/08

Total number of patents in this class: 72

10-year publication summary

4
8
2
3
1
10
2
2
2
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
HTE GmbH The High Throughput Experimentation Company
58
5
1859, Inc.
16
5
Cyclenium Pharma Inc.
11
4
Hypharm GmbH
11
3
The Regents of the University of California
19859
2
Glaxosmithkline Intellectual Property Development Limited
757
2
Massachusetts Institute of Technology
10024
2
The Board of Trustees of the Leland Stanford Junior University
6394
2
National Taiwan University
1216
2
Ginkgo BioWorks, Inc.
259
2
National Health Research Institutes
323
2
The Trustees of Princeton University
1200
2
Merck Patent GmbH
5861
1
California Institute of Technology
3973
1
Life Technologies Corporation
3279
1
The Johns Hopkins University
5651
1
Novozymes A/S
3319
1
Vertex Pharmaceuticals Incorporated
1595
1
Affinity Biosciences Pty Ltd
10
1
AV Therapeutics, Inc.
2
1
Other owners 31